Givendazole Tablet (Albendazole)
Albendazole 400mg
OTC medication
Ari Pharmaceutical Co., Ltd.
MFDS item code 202006253 · Notified 2020.09.09
This product's status changed to Expired on 2025.09.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of parasitic infections (such as roundworm and pinworm infections) and mixed infections
This medication is used for the treatment of parasitic infections caused by roundworms, pinworms, hookworms, whipworms, Ancylostoma duodenale, and Strongyloides stercoralis, including cases of mixed infections with these parasites. It helps to effectively treat the parasitic infections, alleviate symptoms, and restore health.
Adults should take the following doses: 1) Pinworm: Take 400 mg of albendazole once daily. To ensure eradication, take another 400 mg of this medicine once, 7 days later. 2) Ascaris, hookworm, whipworm, and American hookworm: Take 400 mg of this medicine as a single dose. 3) Other parasitic infections (tapeworm) associated with strongyloidiasis and severe mixed infections: Take 400 mg of this medicine once daily for 3 days. - If swallowing is difficult, the tablet may be chewed or taken with a small amount of water. No special measures, such as stopping meals or using a laxative, are necessary (applies to tablets and chewable tablets only). - Have an examination 3 weeks after treatment. If the infection has not been cured, a second course may be given as appropriate.
Children aged 24 months and older 1) Pinworm: Take 400 mg of albendazole once daily. To achieve eradication, take another 400 mg dose of this medicine once, 7 days later. 2) Roundworm, hookworm, whipworm, American hookworm: Take a single 400 mg dose of this medicine. 3) In cases of Strongyloides infection with other parasites (tapeworm) or severe mixed infections: Take 400 mg of this medicine once daily for 3 days.
This medicine contains the artificial sweetener aspartame, which is converted into phenylalanine in the body. Therefore, patients with phenylketonuria should avoid taking this drug. The daily intake of aspartame should be limited to below the WHO recommended amount of 40mg/kg, with a maximum dose of 2.4g per day for adults. This medicine should not be taken by individuals who are allergic to this drug or its components, by women who are pregnant or may become pregnant, nursing mothers, and children under 2 years of age. Additionally, since this drug contains lactose, individuals with lactose intolerance, galactose intolerance, or glucose-galactose malabsorption should also avoid it. It is essential not to take this medication along with certain other drugs. For example, theophylline may interfere with the metabolism of this drug, and cimetidine, praziquantel, and dexamethasone may increase the blood concentration of this drug. On the other hand, ritonavir, phenytoin, carbamazepine, and phenobarbital may decrease the blood concentration of this drug, so these should not be taken together. Patients with liver or kidney function problems should consult a physician or pharmacist before taking this medication. Furthermore, since this medicine contains dye No. 5, caution is needed if there is a history of allergy or hypersensitivity to this component. During the course of taking this drug, if symptoms such as red spots on the skin, severe rashes, itching, headache, dizziness, nausea, vomiting, abdominal pain, etc., occur, immediate discontinuation of the drug and consultation with a healthcare professional is required. Additionally, fever or hair loss may occur rarely, so monitoring for these changes is also necessary. Women who may become pregnant should verify their pregnancy status before taking this drug and are advised to avoid it in early pregnancy. Animal studies have reported that this medication can harm the fetus, so effective contraception should be utilized during and for three days after treatment. This medication may occasionally cause decreased white blood cell counts or increased liver enzyme levels, so regular blood tests may be necessary. In case of overdose, symptomatic treatment such as gastric lavage may be required. If neurological symptoms (seizures, headaches, increased intracranial pressure, etc.) appear during treatment for intra-cerebral parasites after taking this drug, immediate consultation with healthcare professionals is necessary. Lastly, this medicine should be kept out of the reach of children and stored in a cool, dry place away from direct sunlight. Additionally, it should not be transferred to other containers to maintain quality and avoid misuse or abuse.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent air ingress, and it should be stored safely at room temperature between 1 degree and 30 degrees Celsius.
Pale orange film-coated elliptical tablet
2 tablets/box [(2 tablets/PTP*1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Albendazole 400mg
OTC medication
Ari Pharmaceutical Co., Ltd.

Albendazole 400mg
Tablet · OTC medication
Yuhan Corporation
Albendazole
OTC medication
Withus Pharmaceutical Co., Ltd.
Albendazole
OTC medication
HighPharm Life Science Co., Ltd.

Albendazole 400mg
Tablet · OTC medication
Chong Kun Dang Pharmaceutical Corp.
Albendazole 400mg
Tablet · OTC medication
Chodang Pharmaceutical Co., Ltd.
Albendazole 200mg
Tablet · OTC medication
Chodang Pharmaceutical Co., Ltd.
Albendazole
OTC medication
Unimed Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.